LWCFA
RCPI

Loring Wolcott & Coolidge Fiduciary Advisors’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,000
Closed -$3K – 703
2015
Q3 		$3K Hold
2,000
– – ﹤0.01% 596
2015
Q2 		$3K Hold
2,000
– – ﹤0.01% 596
2015
Q1 		$5K Hold
2,000
– – ﹤0.01% 596
2014
Q4 		$9K Hold
2,000
– – ﹤0.01% 567
2014
Q3 		$14K Buy
2,000
+400
+25% +$3.95K ﹤0.01% 510
2014
Q2 		$24K Buy
+1,600
New +$27.8K ﹤0.01% 497

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 13.41% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's RCPI Position: Q4 2015 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 2,000 shares — an estimated $3K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in RCPI in Q2 2014 and held it in 6 quarters. The position peaked at $24K in Q2 2014. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 2,000 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $3K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 6 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $24K in Q2 2014.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2015, filed 27 Jan 2016.